TOGA
@togaanz.bsky.social did:plc:7jhpmq23tkwbluvrqmzvu5lq
The leading thoracic cancer clinical trials group in Australia and New Zealand
No Bluesky desde
- Seguidores
- 223
- Seguindo
- 136
- Posts
- 1.101
- Dias nos rankings
- 0
Resumo
TOGA (@togaanz.bsky.social) é um usuário do Bluesky desde 20 novembro 2024. Tem 223 seguidores, segue 136 contas e publicou 1.101 posts.
Aparições nos rankings
Os melhores dias em que posts desta conta entraram na lista diária do Debya.
Esta conta ainda não apareceu em um ranking diário.
Posts curtidos recentemente
Curtidas públicas da rede Bluesky.
Very grateful to be invited to present at this @togaanz.bsky.social webinar! Will highlight some of the exciting translational research we've been doing in @sutherlandlab.bsky.social at @wehi-research.bsky.social
Ver postSharing and reusing clinical trials data means researchers can do more with less. 📘 Explore our practical guide to find out how to conduct impactful research using secondary data, avoid common errors, develop your skills and improve your research practices: https://ow.ly/qNBc50Y1xt9 #HealthData
Ver postIdentifying ALK+ resistance pathways is at the very core of what is important to us all. That makes the announcement of Dr Vassiliadis as the recipient of the ALK Positive Australia/TOGA Inspirational Grant for 2026 so thrilling. Every $ donated to ALK Positive Australia goes towards research.
Ver postA must watch for anyone interested in ALK+ Lung Cancer & the advances being made in personalising treatment plans & understanding the behaviour of this cancer. A/Prof Chin talks about her incredible research project (funded by the TOGA/ALK+ Australia Inspirational grant). youtu.be/w9M-4M9fNT8
Ver postThis recent presentation on the ALK+ vaccine & current research being undertaken in the US is truly a MUST WATCH. It brings true hope. Thank you to everyone involved, we are cheering you on from Down Under! youtu.be/GxrUsGIAFUs?...
Ver post
Contas que bloqueia
No Bluesky, bloqueios são registros públicos.
Esta conta não bloqueia ninguém.